Thursday, July 11, 2019

To view the WHII 2019 program, please click on the below days

HALL A
09:00-10:00 Plenary Session 20: Good Morning Tel Aviv - Connecting Industry to Women Health
Moderators: Yariv Yogev, Israel and TBD
09:00-09:20 The management of endometriosis: Opportunities and challenges to address this unmet need: Felice Petraglia, Italy
09:20-09:40 Women’s health and the omics: Vassillios Fanos, Italy
09:40-10:00 TBD
DEFINING THE UNMET NEED
HALL A HALL B HALL C HALL D
10:00-11:30 Session 21: Inventions and Innovations leading to New Technologies: The Omics Session 22: Technology Transfer Offices: From Academic Research to Industry I Addressing the unmet needs – Reproduction Session 23: Women Health Issues in Low and Middle Income Counties (LMIC) - A New Global Agenda Session 24: Medical Cannabis and Women’s Health - Addressing Unmet Needs; Towards Evidence-Based Therapeutics
Moderators: Moshe Hod, Israel and TBD Shlomo Nimrodi, Israel and TBD Neerja Bathla, India and Hema Divakar, India Esther Barak Landes, Israel and Meredith Rose Burak, USA
The metabolomics: Vassilios Fanos, Italy TBD Addressing maternal mortality – How to win the Nobel prize; Simple innovations to address the leading causes of maternal mortality worldwide:Richard Derman, USA The laboratory – strains and formulas in cannabinoid research: Lumír Ondřej Hanuš, Israel
The Proteomics: Liona Poon, Hong Kong Addressing the Non Communicable Disease pandemic: TBD From the bench to clinical practice – supplying the evidence: Sari Prutchi Sagiv, Israel and Yehoshua Maor, Israel
The Microbiome: Omry Koren, Israel Can new technologies close the gap of caring for migrant pregnant women globally? Jack Ludmir, USA Connecting big data to cannabis based therapeutics - Database of medical cannabis effects on women's health: Michelle Arbus, Strainprint, Canada
The Small RNSs: Noam Shomron, Israel Company Presentations Company Presentations
Company Presentations
11:30-12:00 Coffee Break
HALL A HALL B HALL D HALL C
12:00:13:30 Session 25: Fetal Growth Session 26: Technology Transfer Offices - From Academic Research to Industry II Addressing the unmet needs – Oncology Session 27: Innovative approach to Contraception - addressing the unmet needs Session 28: Medical Cannabis and Women’s Health - Addressing Unmet Needs; A community for professional women - Improving women's positioning in the cannabis industry
Moderators: Jason Gardosi, UK and TBD Shlomo Nimrodi, Israel and TBD Daniel S. Seidman, Israel Yona Tadir, Israel and TBD
Fetal Growth – the ultimate challenge: Improved antenatal detection reduces adverse outcome: Jason Gardosi, UK Natural Cycles - Digital Contraception: TBD The patient perspective: Nitzan Bernstein, Israel
Machine learning approach to fetal weight estimation - a proof of concept study: Ido Solt, Israel Contraceptive apps: Are they an effective option? TBD TBD
The less often spoken of extreme: macrosomia. Can shoulder dystocia be avoided? Jacques S. Abramowicz, USA The FDA's digital health pre-certification pilot program and the use of real world evidence: TBD
Contraception: past, present and future and why it matters TBD
Company Presentations Company Presentations Company Presentations
13:30-14:30 Lunch Break
HALL A HALL B HALL D HALL C
14:30-16:00 Session 29: Prevention of Future Non Communicable Disease – Big Data Wisdom Session 30: Investment in FemTech – Opportunities and Challenges Session 31: Female Pelvic Floor Disorders – Innovative Solutions
Moderators: Eyal Sheiner, Israel and TBD Benny Zeevi, Israel and TBD Jack Baniel, Israel and TBD
Unacceptable: Time for extending the criteria for women at risk for CVD: The long-term complications of pregnancy placental complications: Eyal Sheiner, Israel Panel of Venture Capitalists The unmet needs in female pelvic floor disorders: Jack Baniel, Israel
Preeclampsia and long-term maternal atherosclerosis disease: A link to endothelial dysfunction: Yoav Yinon, Israel Irit Yaniv, Israel Upcoming new era in the treatment of pelvic floor disorders in women: Shift of control into the hands of the patient: Elan Ziv, ConTiPi Medical, Israel
Intra-uterine growth restriction and long-term disease of the offspring: Tal Biron-Shental, Israel Orit Alperovitz, Israel Truly minimal invasive vaginal reconstructive procedure for apical prolapse: Menahem Neuman, POP Medical Solutions Israel
Unacceptable: Early-term induction without clear indication: The long term implication of the early term to offspring Asnat Walfisch, Israel Anula Jayasuriya, USA Discussion – Surgical or conservative approach?
Patients Perspective: An obstetrician with GDM-long-term personal perspectives: Shiran Zer, Israel
Company Presentations
Company Presentations Company Presentations
16:00-16:30 Coffee Break
HALL A HALL B HALL D HALL C
16:30-18:00 Session 32: The GENOME and Women’s Health Life Cycle Session 33: Improving Women’s Health with Energy-Based Technologies Session 34: New surgical Technologies - Minimally Invasive, laparoscopy
Moderators: TBD and Lior Soussan Gutman, Israel Yona Tadir, Israel and TBD Chen Goldchmit, Israel and TBD
Fertilome - Comprehensive genetic testing for female fertility: the key to precision personalized care: Daniel S. Seidman, Israel Vaginal Robotic Surgery: Menahem Neuman, Israel
Karotype, microarray and whole genome sequencing; Which test should we order? Lorraine Dugoff, USA Laparoscopic Vaginal Surgery: TBD
Establishing Non-Invasive Prenatal Testing in Routine Practice in Israel: Adi Reches, Israel Single site and mini-laparoscopy: Chen Goldchmit, Israel
Company Presentations Company Presentations Company Presentations
18:00-18:15 Technical Break
HALL A
18:00-18:15 Closing Remarks